Clinical Trial: Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss

U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07382544) titled 'Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss' on Dec. 29, 2025.

Brief Summary: The goal of this clinical research study is to learn about the safety and effects of BMS-986504 in combination with olaparib in patients with advanced solid tumors with MTAP loss.

Study Start Date: June 01, 2026

Study Type: INTERVENTIONAL

Condition: Advanced Cancer Solid Tumor

Intervention: DRUG: MRTX1719

Given by mouth

DRUG: Olaparib

Given by mouth

Recruitment Status: NOT_YET_RECRUITING

Sponsor: M.D. Anderson Cancer Center

Disclaimer: Curated by HT Syndication....